Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
70%
OVERLAP
BY WEIGHT
BY WEIGHT
60
# OF OVERLAPPING HOLDINGS
FHLC
349
HOLDINGS
19%
ALSO IN IXJ
IXJ
114
HOLDINGS
54%
ALSO IN FHLC
SECTOR DRIFT (FHLC minus IXJ)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in IXJ |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.3% | 8.8% | 8.8% |
|
JOHNSON & JOHNSON | 6.4% | 5.3% | 5.3% |
|
ABBVIE INC | 6.1% | 4.6% | 4.6% |
|
UNITEDHEALTH GROUP INC | 7.3% | 4.0% | 4.0% |
|
ABBOTT LABORATORIES | 3.8% | 3.4% | 3.4% |
FHLC Overweight Relative to IXJ
|
UNITEDHEALTH GROUP INC | 3.2% |
|
ELI LILLY & CO | 2.5% |
|
ABBVIE INC | 1.4% |
|
JOHNSON & JOHNSON | 1.2% |
|
THERMO FISHER SCIENTIFIC INC | 1.0% |
|
MERCK & CO. INC. | 1.0% |
|
AMGEN INC | 0.7% |
|
BRISTOL-MYERS SQUIBB CO | 0.6% |
|
VEEVA SYSTEMS INC-CLASS A | 0.6% |
|
ALNYLAM PHARMACEUTICALS INC | 0.5% |
FHLC Underweight Relative to IXJ
 |
ROCHE HOLDING LTD | -3.3% |
|
NOVARTIS AG | -3.3% |
 |
ASTRAZENECA PLC | -3.1% |
 |
NOVO NORDISK A/S-B | -3.1% |
 |
SANOFI-AVENTIS | -1.5% |
|
GSK PLC | -1.1% |
|
ESSILOR INTERNATIONAL | -1.1% |
 |
CSL LIMITED | -1.1% |
|
LONZA GROUP AG-REG | -0.7% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -0.7% |